Table 3.
Association between baseline characteristics and postvaccination antibody values in the obese adolescent group.
| Factors (n) | Antibody Levels (IU/mL) | p-Value |
|---|---|---|
| Steatosis | ||
| -None–mild (11) | 2342 (1759–3834.7) | 0.79 |
| -Moderate–severe (13) | 2772.5 (1914.3–4513.5) | |
| Liver stiffness measurement | ||
| -LSM < 5.5 kPa (5) | 4228 (2165–6762.5) | 0.03 |
| -LSM ≥ 5.5 kPa (19) | 2344 (1092–2924) | |
| Comorbid T2DM | ||
| -yes (8) | 2801.5 (2001.2–4870.5) | 0.59 |
| -no (16) | 2497.5 (1684.7–3871.3) | |
| Truncal obesity | ||
| -yes (20) | 2667 (1914.5–4027.5) | 0.09 |
| -no (4) | 2496 (1336–6350.75) | |
| Acanthosis nigricans | ||
| -yes (16) | 2699 (1914.5–4027.5) | 0.69 |
| -no (8) | 2496 (1759.5–5125.5) |
Data expressed as median (IQR).